2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association of Genetic Variation With Keratoconus

      research-article
      , PhD 1 , , , PhD 2 , 3 , , PhD 4 , 5 , 6 , , MD, FRCOphth 7 , 8 , , BSc (Hons) 2 , , FRANZCO 9 , 10 , 11 , , PhD 1 , , PhD 12 , , MD, PhD, FRANZCO 13 , , PhD 1 , , PhD, FRANZCO 14 , , MD, FRANZCO 15 , , MD 16 , 17 , , PhD 13 , , PhD 18 , , MD 16 , 17 , , PhD 16 , 17 , , PhD, FRANZCO 1 , 2 , , MD 4 , 5 , 6 , , PhD 2 , 3 , , DPhil, FRANZCO 1 , 14 , , PhD 1 , 14
      JAMA Ophthalmology
      American Medical Association

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Which genetic loci are associated with keratoconus?

          Findings

          In this case-control genome-wide association study of a discovery cohort and 3 independent replication cohorts, a locus containing multiple variants across 6 protein-coding genes on chromosome 11 was associated with keratoconus. Several of these genes are likely involved in apoptotic pathways.

          Meaning

          This study of patients with keratoconus and control participants showed a potential role of genes involved in apoptotic pathways.

          Abstract

          This case-control, genome-wide association study assesses genetic susceptibility regions for keratoconus via a genome-wide association study of a discovery cohort and 3 independent replication cohorts from the United States, Northern Ireland, and Australia.

          Abstract

          Importance

          Keratoconus is a condition in which the cornea progressively thins and protrudes in a conical shape, severely affecting refraction and vision. It is a major indication for corneal transplant. To discover new genetic loci associated with keratoconus and better understand the causative mechanism of this disease, we performed a genome-wide association study on patients with keratoconus.

          Objective

          To identify genetic susceptibility regions for keratoconus in the human genome.

          Design, Setting, and Participants

          This study was conducted with data from eye clinics in Australia, the United States, and Northern Ireland. The discovery cohort of individuals with keratoconus and control participants from Australia was genotyped using the Illumina HumanCoreExome single-nucleotide polymorphism array. After quality control and data cleaning, genotypes were imputed against the 1000 Genomes Project reference panel (phase III; version 5), and association analyses were completed using PLINK version 1.90. Single-nucleotide polymorphisms with P < 1.00 × 10 −6 were assessed for replication in 3 additional cohorts. Control participants were drawn from the cohorts of the Blue Mountains Eye Study and a previous study of glaucoma. Replication cohorts were from a previous keratoconus genome-wide association study data set from the United States, a cohort of affected and control participants from Australia and Northern Ireland, and a case-control cohort from Victoria, Australia. Data were collected from January 2006 to March 2019.

          Main Outcomes and Measures

          Associations between keratoconus and 6 252 612 genetic variants were estimated using logistic regression after adjusting for ancestry using the first 3 principal components.

          Results

          The discovery cohort included 522 affected individuals and 655 control participants, while the replication cohorts included 818 affected individuals (222 from the United States, 331 from Australia and Northern Ireland, and 265 from Victoria, Australia) and 3858 control participants (2927 from the United States, 229 from Australia and Northern Ireland, and 702 from Victoria, Australia). Two novel loci reached genome-wide significance (defined as P < 5.00 × 10 −8), with a P value of 7.46 × 10 −9 at rs61876744 in patatin-like phospholipase domain–containing 2 gene ( PNPLA2) on chromosome 11 and a P value of 6.35 × 10 −12 at rs138380, 2.2 kb upstream of casein kinase I isoform epsilon gene ( CSNK1E) on chromosome 22. One additional locus was identified with a P value less than 1.00 × 10 −6 in mastermind-like transcriptional coactivator 2 ( MAML2) on chromosome 11 ( P = 3.91 × 10 −7). The novel locus in PNPLA2 reached genome-wide significance in an analysis of all 4 cohorts ( P = 2.45 × 10 −8).

          Conclusions and Relevance

          In this relatively large keratoconus genome-wide association study, we identified a genome-wide significant locus for keratoconus in the region of PNPLA2 on chromosome 11.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts.

          The primary aim of genome-wide association studies is to identify novel genetic loci associated with interindividual variation in the levels of risk factors, the degree of subclinical disease, or the risk of clinical disease. The requirement for large sample sizes and the importance of replication have served as powerful incentives for scientific collaboration. Methods- The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium was formed to facilitate genome-wide association studies meta-analyses and replication opportunities among multiple large population-based cohort studies, which collect data in a standardized fashion and represent the preferred method for estimating disease incidence. The design of the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium includes 5 prospective cohort studies from the United States and Europe: the Age, Gene/Environment Susceptibility-Reykjavik Study, the Atherosclerosis Risk in Communities Study, the Cardiovascular Health Study, the Framingham Heart Study, and the Rotterdam Study. With genome-wide data on a total of about 38 000 individuals, these cohort studies have a large number of health-related phenotypes measured in similar ways. For each harmonized trait, within-cohort genome-wide association study analyses are combined by meta-analysis. A prospective meta-analysis of data from all 5 cohorts, with a properly selected level of genome-wide statistical significance, is a powerful approach to finding genuine phenotypic associations with novel genetic loci. The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium and collaborating non-member studies or consortia provide an excellent framework for the identification of the genetic determinants of risk factors, subclinical-disease measures, and clinical events.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mutation altering the miR-184 seed region causes familial keratoconus with cataract.

            MicroRNAs (miRNAs) bind to complementary sequences within the 3' untranslated region (UTR) of mRNAs from hundreds of target genes, leading either to mRNA degradation or suppression of translation. We found that a mutation in the seed region of miR-184 (MIR184) is responsible for familial severe keratoconus combined with early-onset anterior polar cataract by deep sequencing of a linkage region known to contain the mutation. The mutant form fails to compete with miR-205 (MIR205) for overlapping target sites on the 3' UTRs of INPPL1 and ITGB4. Although these target genes and miR-205 are expressed widely, the phenotype is restricted to the cornea and lens because of the very high expression of miR-184 in these tissues. Our finding highlights the tissue specificity of a gene network regulated by a miRNA. Awareness of the important function of miRNAs could aid identification of susceptibility genes and new therapeutic targets for treatment of both rare and common diseases. Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Does ethnic origin influence the incidence or severity of keratoconus?

              Keratoconus affects all races, yet very little information exists as to the relative frequency in patients of different ethnic origin. We aimed to establish the incidence and severity of keratoconus in Asian and white patients. The hospital records of the ophthalmology department of a large Midlands hospital with a catchment population of approximately 900,000 (87% white, 11% Asian, 2% other) were examined retrospectively for the 10 year period from 1989 to 1998. For the age group 10-44 years the prevalence of keratoconus in Asians and whites was 229 and 57 per 100,000 respectively, a relative prevalence of 4 to 1. The incidence of keratoconus in the same age group was 19.6 and 4.5 per 100,000 per year respectively, a relative incidence of 4.4 to 1. Asians were significantly younger at presentation compared with whites (mean 22.3 +/- 6.5 vs 26.5 +/- 8.5 years, p < 0.0001). A first corneal graft was carried out on 14% of the Asian and 15% of the white patients. Of those having grafts, Asians were significantly younger than white patients at the time of diagnosis (mean 19.1 +/- 4.8 vs 25.7 +/- 7.3 years, p = 0.005) and at operation (mean 21.4 +/- 5.0 vs 28.7 +/- 7.7 years, p = 0.004). The interval from diagnosis to operation, though shorter for Asians, was not significantly different (mean 1.8 +/- 1.4 vs 2.5 +/- 1.7 years, p = 0.2). The results show previously unrecognised racial differences in the hospital presentation of keratoconus in the UK. Compared with white patients, Asians have a fourfold increase in incidence, are younger at presentation and require corneal grafting at an earlier age.
                Bookmark

                Author and article information

                Journal
                JAMA Ophthalmol
                JAMA Ophthalmol
                JAMA Ophthalmol
                JAMA Ophthalmology
                American Medical Association
                2168-6165
                2168-6173
                February 2020
                19 December 2019
                19 December 2020
                : 138
                : 2
                : 174-181
                Affiliations
                [1 ]Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
                [2 ]Centre for Eye Research Australia, Melbourne, Victoria, Australia
                [3 ]Department of Surgery (Ophthalmology), Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia
                [4 ]Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California
                [5 ]Cornea Genetic Eye Institute, Beverly Hills, California
                [6 ]Board of the Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California
                [7 ]Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland, United Kingdom
                [8 ]Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom
                [9 ]Vision Eye Institute, Melbourne, Victoria, Australia
                [10 ]School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia
                [11 ]Melbourne Stem Cell Centre, Melbourne, Victoria, Australia
                [12 ]QIMR Berghofer Medical Research Institute, Brisbane, Australia
                [13 ]Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia
                [14 ]Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia
                [15 ]Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia
                [16 ]Institute for Translational Genomics and Population Science, Los Angeles Biomedical Research Institute, Los Angeles, California
                [17 ]Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California
                [18 ]Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle
                Author notes
                Article Information
                Accepted for Publication: October 25, 2019.
                Corresponding Author: Bennet J. McComish, PhD, Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart 7000, Tasmania, Australia ( bennet.mccomish@ 123456utas.edu.au ).
                Published Online: December 19, 2019. doi:10.1001/jamaophthalmol.2019.5293
                Author Contributions: Drs McComish and Burdon had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Bykhovskaya, Willoughby, Charlesworth, Mills, Rotter, Baird, Craig, Burdon.
                Acquisition, analysis, or interpretation of data: McComish, Sahebjada, Willoughby, Richardson, Tenen, Charlesworth, MacGregor, Mitchell, Lucas, Mackey, Li, Wang, Jensen, Rotter, Taylor, Hewitt, Rabinowitz, Baird, Craig, Burdon.
                Drafting of the manuscript: McComish, Charlesworth, Lucas, Li, Baird.
                Critical revision of the manuscript for important intellectual content: McComish, Sahebjada, Bykhovskaya, Willoughby, Richardson, Tenen, Charlesworth, MacGregor, Mitchell, Mills, Mackey, Wang, Jensen, Rotter, Taylor, Hewitt, Rabinowitz, Baird, Craig, Burdon.
                Statistical analysis: McComish, Sahebjada, Charlesworth, MacGregor, Li, Jensen, Rotter, Taylor, Baird, Burdon.
                Obtained funding: Mills, Mackey, Rotter, Hewitt, Rabinowitz, Baird, Craig, Burdon.
                Administrative, technical, or material support: Bykhovskaya, Willoughby, Richardson, MacGregor, Lucas, Mackey, Rotter, Hewitt, Baird.
                Supervision: Charlesworth, Mitchell, Rotter, Hewitt, Rabinowitz, Baird, Craig, Burdon.
                Conflict of Interest Disclosures: Dr Rotter reported grants from the National Institutes of Health during the conduct of the study. Dr Burdon reported grants from National Health and Medical Research Council during the conduct of the study. No other disclosures were reported.
                Funding/Support: The Genotype–Tissue Expression Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The data used for the analyses described in the manuscript were obtained from the Genotype–Tissue Expression Portal on May 27, 2019. This study was supported by the Australian National Health and Medical Research Council (project grant GNT1104700) and Senior Research Fellowships (grant 1138585 [Dr Baird] and 1059954 [Dr Burdon]). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. The discovery case cohort was funded by a National Health and Medical Research Council Centre for Research Excellence grant (1023911). Control genotype data for the discovery cohort were provided by the International AMD Genetics Consortium genotyped under the Center for Inherited Diseases Research Program (contract number HHSN268201200008I). The US replication cohort is supported in part by the National Eye Institute (grant R01 EY009052). The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences (Clinical Translational Science Institute grant UL1TR001881) and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (grant DK063491) to the Southern California Diabetes Endocrinology Research Center. The Cardiovascular Health Study (control cohort) was supported by the National Heart, Lung, and Blood Institute (grants HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, and U01HL130114), with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided by the National Institute on Aging (grant R01AG023629).
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
                Additional Information: A full list of principal Cardiovascular Health Study investigators and institutions can be found at CHS–NHLBI.org.
                Article
                PMC6990728 PMC6990728 6990728 eoi190090
                10.1001/jamaophthalmol.2019.5293
                6990728
                31855235
                d98af1cf-31b2-416b-84fe-073983973570
                Copyright 2019 American Medical Association. All Rights Reserved.
                History
                : 6 June 2019
                : 25 October 2019
                Categories
                Research
                Research
                Original Investigation
                Online First
                Comments

                Comments

                Comment on this article